| Patent | Date |
|---|
Pyrimidine JAK inhibitors for the treatment of skin diseases
Grant 11,439,641 - Gerken , et al. September 13, 2 | 2022-09-13 |
Ester And Carbonate Pyrimidine Compounds As Jak Kinase Inhibitors
App 20220009926 - Gerken; Philip A. ; et al. | 2022-01-13 |
Hormone Receptor Modulators For Treating Metabolic Mutagenic And Fibrotic Conditions And Disorders
App 20210380585 - Chao; Jianhua | 2021-12-09 |
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
Grant 11,155,549 - Gerken , et al. October 26, 2 | 2021-10-26 |
Isoxazolyl-carbonyloxy Azabicyclo[3.2.1]octanyl Compounds As Fxr Activators
App 20210300927 - Chao; Jianhua ; et al. | 2021-09-30 |
Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators
Grant 11,091,482 - Chao , et al. August 17, 2 | 2021-08-17 |
Hormone Receptor Modulators For Treating Metabolic Conditions And Disorders
App 20210017177 - Chao; Jianhua ; et al. | 2021-01-21 |
Ester And Carbonate Pyrimidine Compounds As Jak Kinase Inhibitors
App 20200339580 - Gerken; Philip A. ; et al. | 2020-10-29 |
Pyrimidine Jak Inhibitors For The Treatment Of Skin Diseases
App 20200338073 - Gerken; Philip A. ; et al. | 2020-10-29 |
Hormone receptor modulators for treating metabolic conditions and disorders
Grant 10,793,568 - Chao , et al. October 6, 2 | 2020-10-06 |
Isoxazolyl-carbonyloxy Azabicyclo[3.2.1]octanyl Compounds As Fxr Activators
App 20190308973 - Chao; Jianhua ; et al. | 2019-10-10 |
Deuterium substituted fumarate derivatives
Grant 10,399,924 - Chao Sep | 2019-09-03 |
Hormone Receptor Modulators For Treating Metabolic Conditions And Disorders
App 20190233420 - Chao; Jianhua ; et al. | 2019-08-01 |
S1P and/or ATX modulating agents
Grant 9,850,206 - Peng , et al. December 26, 2 | 2017-12-26 |
Diterpenoid Derivatives And Methods Of Use Thereof
App 20170354639 - Chao; Jianhua ; et al. | 2017-12-14 |
Silicon-containing fumaric acid esters
Grant 9,421,273 - Chao August 23, 2 | 2016-08-23 |
S1p And/or Atx Modulating Agents
App 20150274663 - Peng; Hairuo ; et al. | 2015-10-01 |
Silicon-Containing Fumaric Acid Esters
App 20140336151 - Chao; Jianhua | 2014-11-13 |
Deuterium Substituted Fumarate Derivatives
App 20140194427 - CHAO; Jianhua | 2014-07-10 |
Deuterium Substituted Fumarate Derivatives
App 20140179779 - CHAO; Jianhua | 2014-06-26 |
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
Grant 8,569,312 - McCormick , et al. October 29, 2 | 2013-10-29 |
Biaryl-spiroaminooxzaoline Analogues As Alpha 2c Adrenergic Receptor Modulators
App 20130225582 - McCormick; Kevin D. ; et al. | 2013-08-29 |
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators
Grant 8,476,274 - McCormick , et al. July 2, 2 | 2013-07-02 |
Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonists
Grant 8,470,863 - Zheng , et al. June 25, 2 | 2013-06-25 |
Reversed Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators
App 20130079271 - McCormick; Kevin D. ; et al. | 2013-03-28 |
Functionally selective alpha2C adrenoreceptor agonists
Grant 8,383,818 - Zheng , et al. February 26, 2 | 2013-02-26 |
Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators
App 20130045914 - McCormick; Kevin D. ; et al. | 2013-02-21 |
Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators
Grant 8,324,213 - McCormick , et al. December 4, 2 | 2012-12-04 |
Functionally Selective Azanitrile Alpha-2c Adrenoreceptor Agonists
App 20120028940 - Boyce; Christopher W. ; et al. | 2012-02-02 |
Biaryl-spiroaminooxazoline Analogues As Alpha 2c Adrenergic Receptor Modulators
App 20110251207 - McCormick; Kevin D. ; et al. | 2011-10-13 |
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands
App 20110213029 - Taveras; Arthur G. ; et al. | 2011-09-01 |
Tricyclic Spirocycle Derivatives And Methods Of Use
App 20110166124 - McCormick; Kevin D. ; et al. | 2011-07-07 |
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
Grant 7,964,646 - Taveras , et al. June 21, 2 | 2011-06-21 |
Treatment of chemokine mediated diseases
Grant 7,960,433 - Taveras , et al. June 14, 2 | 2011-06-14 |
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
Grant 7,947,720 - Taveras , et al. May 24, 2 | 2011-05-24 |
Functionally Selective Alpha2C Adrenoreceptor Agonists
App 20110060006 - Zheng; Junying ; et al. | 2011-03-10 |
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H.sub.3 antagonists
Grant 7,846,946 - Aslanian , et al. December 7, 2 | 2010-12-07 |
Oxypiperidine Derivatives And Methods Of Use Thereof
App 20100249098 - Chao; Jianhua ; et al. | 2010-09-30 |
Thiadiazoles as CXC- and CC- chemokine receptor ligands
Grant 7,786,149 - Biju , et al. August 31, 2 | 2010-08-31 |
Derivatives And Analogs Of Chroman As Functionally Selective Alpha2c Adrenoreceptor Agonists
App 20100168195 - Zheng; Junying ; et al. | 2010-07-01 |
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
Grant 7,691,856 - Taveras , et al. April 6, 2 | 2010-04-06 |
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
Grant 7,671,212 - Taveras , et al. March 2, 2 | 2010-03-02 |
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H.sub.3 antagonists
Grant 7,635,705 - Aslanian , et al. December 22, 2 | 2009-12-22 |
3,4-di-substituted Cyclobutene-1,2-diones As Cxc-chemokine Receptor Ligands
App 20090306079 - Taveras; Arthur G. ; et al. | 2009-12-10 |
Heteroatom-linked Substituted Piperidines And Derivatives Thereof Useful As Histamine H3 Antagonists
App 20090286830 - Aslanian; Robert G. ; et al. | 2009-11-19 |
Thiadiazoles As Cxc- And Cc- Chemokine Receptor Ligands
App 20080090823 - Biju; Purakkattle J. ; et al. | 2008-04-17 |
Thiadiazoles AS CXC- and CC- chemokine receptor ligands
Grant 7,338,968 - Biju , et al. March 4, 2 | 2008-03-04 |
3,4-di-substituted Cyclobutene-1,2-diones As Cxc-chemokine Receptor Ligands
App 20080045489 - Chao; Jianhua ; et al. | 2008-02-21 |
CXCR1 and CXCR2 chemokine antagonists
Grant 7,326,729 - Chao , et al. February 5, 2 | 2008-02-05 |
Functionally selective alpha2C adrenoreceptor agonists
App 20080027100 - McCormick; Kevin D. ; et al. | 2008-01-31 |
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
App 20070264230 - Taveras; Arthur G. ; et al. | 2007-11-15 |
Cxcr1 And Cxcr2 Chemokine Antagonists
App 20070248594 - Chao; Jianhua ; et al. | 2007-10-25 |
Treatment of chemokine mediated diseases
App 20070155756 - Taveras; Arthur G. ; et al. | 2007-07-05 |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
App 20070021494 - Taveras; Arthur G. ; et al. | 2007-01-25 |
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
App 20070015807 - Aslanian; Robert G. ; et al. | 2007-01-18 |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
Grant 7,132,445 - Taveras , et al. November 7, 2 | 2006-11-07 |
Thiadiazoles AS CXC- and CC- chemokine receptor ligands
App 20060223864 - Biju; Purakkattle J. ; et al. | 2006-10-05 |
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
App 20060025453 - Taveras; Arthur G. ; et al. | 2006-02-02 |
CXCR1 and CXCR2 chemokine antagonists
App 20060014794 - Chao; Jianhua ; et al. | 2006-01-19 |
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
Grant 6,878,709 - Taveras , et al. April 12, 2 | 2005-04-12 |
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligands
App 20040186142 - Taveras, Arthur G. ; et al. | 2004-09-23 |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
App 20040147559 - Taveras, Arthur G. ; et al. | 2004-07-29 |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
App 20040106794 - Taveras, Arthur G. ; et al. | 2004-06-03 |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
App 20040097547 - Taveras, Arthur G. ; et al. | 2004-05-20 |
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
App 20040063709 - Taveras, Arthur G. ; et al. | 2004-04-01 |
Treatment of chemokine mediated diseases
App 20040053953 - Taveras, Arthur G. ; et al. | 2004-03-18 |
| 